Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The cancer access partnership
Prof Richard Sullivan and Emily Kobayashi
The cancer access partnership ( Prof Richard Sullivan and Emily Kobayashi )
6 Oct 2022
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unrese...
Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022
How to read a clinical trial?
Prof Ian Tannock - Emeritus Professor of Medical Oncology, Princess Margaret Can...
How to read a clinical trial? ( Prof Ian Tannock - Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada )
25 Sep 2022
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced br...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
21 Sep 2022
Challenges to developing the quality of complex cancer surgery in LMICs
Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India
Challenges to developing the quality of complex cancer surgery in LMICs ( Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India )
19 Sep 2022
Early palliative care in India
Dr M.R Rajagopal - Trivandrum Institute of Palliative Sciences, Kerala, India
Early palliative care in India ( Dr M.R Rajagopal - Trivandrum Institute of Palliative Sciences, Kerala, India )
19 Sep 2022
Trials in LMIC and HIC – are the standards applicable globally ?
Dr Amol Patel - INHS Asvini, Mumbai, India
Trials in LMIC and HIC – are the standards applicable globally ? ( Dr Amol Patel - INHS Asvini, Mumbai, India )
19 Sep 2022
Interpreting statistics in clinical trials
Dr Sudeep Gupta - Tata Medical Centre, Mumbai, India
Interpreting statistics in clinical trials ( Dr Sudeep Gupta - Tata Medical Centre, Mumbai, India )
19 Sep 2022
Choosing Wisely and the National Cancer grid efforts in reducing low value cance...
Dr CS Pramesh - Tata Memorial Hospital, Mumbai, India
Choosing Wisely and the National Cancer grid efforts in reducing low value cancer care in India ( Dr CS Pramesh - Tata Memorial Hospital, Mumbai, India )
18 Sep 2022
Cancer survivors' stories: An African perspective
Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation
Cancer survivors' stories: An African perspective ( Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation )
15 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022
Neoadjuvant immunotherapy improves outlook in high-risk melanoma
Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA
Neoadjuvant immunotherapy improves outlook in high-risk melanoma ( Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA )
14 Sep 2022